Vietnam’s VinaCapital and Japan’s Daiwa PI Partners have sold the remainder of their interest in Vietnamese dairy producer International Dairy Products (IDP).
Last month, the two investors had agreed to sell a 28% stake to a consortium led by local consumer goods investor Blue Point for an undisclosed sum. They have now received $45.7 million for the remaining...
Hangzhou-based drug developer Sumgen Biotech has raised RMB220 million ($32 million) in a Series B funding led by Addor Capital.
Increased climate change awareness on a corporate level is leading to more investment – either direct or through funds – in start-ups that offer mitigation solutions. Asia is a key geography
Healthcare-focused Panacea Venture has led a $40 million Series C round for China’s XWPharma, a neurobiology-focused biotech developer previously known as XW Laboratories.
Kyee Technology, a Chinese digital medical platform has raised RMB430 million ($64 million) in a Series D round led by Tencent Holdings. Other investors include Longmen Capital, Dyee Capital and Royal Sea Capital.